Esophageal Squamous Cell Carcinoma
Innovent and Lilly Receive the NMPA’s Approval for Tyvyt (sintilimab) sNDA as 1L Treatment for Esophageal Squamous Cell Carcinoma
June 21, 2022
BMS’ Opdivo (nivolumab) + Yervoy (ipilimumab) Receives the US FDA Approval as 1L Treatment for Unresectable Advanced or Metastatic...
May 30, 2022
BeiGene Reports Results of Tislelizumab in P-III (RATIONALE 306) Trial as 1L Treatment of Advanced Esophageal Squamous Cell Carcin...
April 27, 2022
BeiGene’s Tislelizumab Receives the NMPA’s Approval as a 2L Treatment for Esophageal Squamous Cell Carcinoma
April 18, 2022
Junshi Biosciences and Coherus Publishes Results of Toripalimab in P-III (JUPITER-06) Study for Esophageal Squamous Cell Carcinoma...
March 7, 2022
No more records!
Incisive News in 3 Shots.
First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2022 PharmaShots - All Rights Reserved.